P
BMRN icon

PensionDanmark’s BioMarin Pharmaceuticals BMRN Stock Holding History

PensionDanmark’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$568K Hold
9,935
– – ﹤0.01% 540
2026
Q1 		$561K Sell
9,935
-641
-6% -$37.4K 0.01% 551
2025
Q4 		$629K Buy
+10,576
New +$576K 0.01% 531

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

PensionDanmark's BMRN Position: Q2 2026 in Review

PensionDanmark held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 9,935 shares worth $568K. The position accounts for ﹤0.01% of the portfolio, ranked #540.

PensionDanmark first reported a position in BMRN in Q4 2025 and has held it in 3 quarters since. The position peaked at $629K in Q4 2025. 562 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • PensionDanmark held 9,935 shares of BioMarin Pharmaceuticals worth $568K as of Q2 2026.
  • PensionDanmark left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
  • BioMarin Pharmaceuticals made up ﹤0.01% of PensionDanmark's portfolio in Q2 2026, its #540 holding.
  • PensionDanmark first reported a position in BioMarin Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • PensionDanmark's BioMarin Pharmaceuticals position peaked at $629K in Q4 2025.
  • 562 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on PensionDanmark's 13F filing for Q2 2026, filed 8 Jul 2026.